Morphic Shows Potential For An ‘Oral Entyvio’ With Phase IIa Data

 
• By Joseph Haas
  
Biz competition
Morphic made progress in the race for an oral therapy in UC • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D